According to the Centers for Disease Control and Prevention (CDC), there are no specific guidelines for the minimum waiting period between receiving Cosentyx (secukinumab) and a flu shot. However, the CDC recommends that individuals on immunosuppressive therapies, including biologics like Cosentyx, receive the flu vaccine as soon as possible, ideally before the flu season starts, but not later than 4-6 weeks after starting therapy [1].

In a study published by the American Academy of Dermatology, researchers found that patients on various biologic therapies, including secukinumab, have a weakened immune response to the flu vaccine. The study suggests that patients with compromised immune systems, including those taking biologics, may benefit from receiving the flu vaccine again 1-2 months after the initial vaccination [2].

It is essential to consult with your healthcare provider for personalized advice, as the recommended gap between Cosentyx and a flu shot may vary depending on individual circumstances.

[1]: https://www.cdc.gov/flu/prevent/who-should-get-vaccinated.htm

[2]: https://jcadonline.com/article/S0190-9622(20)31119-2/fulltext

Sources:

1. Centers for Disease Control and Prevention. (n.d.). Who Should Get Vaccinated Against Flu? Retrieved from https://www.cdc.gov/flu/prevent/who-should-get-vaccinated.htm
2. American Academy of Dermatology. (n.d.). Biologics: What’s the best time to get a flu vaccine. Retrieved from https://jcadonline.com/article/S0190-9622(20)31119-2/fulltext